St. Jude Medical Center is a faith-based, not-for-profit hospital, located in Fullerton, California, which was established by the Sisters of St. Joseph of Orange in 1957.

There are 320 beds in St. Joseph Heritage Healthcare.

During the past decade, St. Joseph Heritage Healthcare conducted 105 clinical trials. In the 10-year time frame, 105 clinical trials started and 79 clinical trials were completed, i.e. on average, 75.2% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 52 clinical trials were completed. i.e. 115.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Joseph Heritage Healthcare" #1 sponsor was "Pfizer" with 22 trials, followed by "Eli Lilly and Company" with 13 trials sponsored, "Bristol-Myers Squibb" with 11 trials sponsored, "Clovis Oncology, Inc." with 6 trials sponsored and "Gilead Sciences" with 6 trials sponsored. Other sponsors include 82 different institutions and companies that sponsored additional 63 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Joseph Heritage Healthcare" #1 collaborator was "Incyte Corporation" with 4 trials as a collaborator, "Medivation, Inc." with 4 trials as a collaborator, "ARMO BioSciences" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "Foundation Medicine" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "St. Joseph Heritage Healthcare" are "Breast Cancer" (11 trials), "Rheumatoid Arthritis" (11 trials), "Breast Neoplasms" (7 trials), "Non-Small Cell Lung Cancer" (7 trials) and "Cancer" (5 trials). Many other conditions were trialed in "St. Joseph Heritage Healthcare" in a lesser frequency.

Most popular intervention types in "St. Joseph Heritage Healthcare" are "Drug" (126 trials), "Biological" (23 trials), "Other" (14 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "Pembrolizumab" (8 trials), "Abemaciclib" (6 trials), "Gemcitabine" (6 trials) and "Nivolumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "St. Joseph Heritage Healthcare" are 122 trials for "All" genders, 16 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "St. Joseph Heritage Healthcare". undefined are not yet recruiting, 29 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 64 completed trials in St. Joseph Heritage Healthcare, undefined suspended trials, and 34 terminated clinical trials to date.

Out of the total trials that were conducted in St. Joseph Heritage Healthcare, 13 "Phase 1" clinical trials were conducted, 62 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 3 trials that are defined as “Not Applicable".